BioLineRx (BLRX)
(Delayed Data from NSDQ)
$0.71 USD
+0.06 (9.35%)
Updated Jul 12, 2024 03:59 PM ET
After-Market: $0.72 +0.01 (0.88%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 9/4/24 |
---|---|
Current Quarter | -0.08 |
EPS Last Quarter | -0.01 |
Last EPS Surprise | 96.55% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.25 |
Next Year | -0.23 |
EPS (TTM) | -0.76 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.93M | 4.76M | 21.06M | 23.98M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 4.92M | 5.86M | 24.55M | 25.40M |
Low Estimate | 2.94M | 3.66M | 17.57M | 22.56M |
Year ago Sales | 0.00M | 0.00M | 4.80M | 21.06M |
Year over Year Growth Est. | NA | NA | 338.75% | 13.87% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.08 | -0.09 | -0.25 | -0.23 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.01 | -0.01 | -0.03 | -0.03 |
High Estimate | -0.01 | -0.01 | -0.03 | -0.03 |
Low Estimate | -0.14 | -0.17 | -0.47 | -0.42 |
Year ago EPS | -0.30 | -0.30 | -0.94 | -0.25 |
Year over Year Growth Est. | 73.33% | 70.00% | 73.40% | 10.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.08 | -0.09 | -0.25 | -0.23 |
7 Days Ago | -0.08 | -0.09 | -0.25 | -0.23 |
30 Days Ago | -0.08 | -0.09 | -0.25 | -0.23 |
60 Days Ago | -0.29 | -0.24 | -0.53 | -0.47 |
90 Days Ago | -0.29 | -0.24 | -0.53 | -0.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.08 | -0.09 | -0.25 | -0.23 |
Zacks Consensus Estimate | -0.08 | -0.09 | -0.25 | -0.23 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.01 | -0.15 | -0.30 | -0.30 | NA |
Estimate | -0.29 | -0.22 | -0.18 | -0.16 | NA |
Difference | 0.28 | 0.07 | -0.12 | -0.14 | 0.02 |
Surprise | 96.55% | 31.82% | -66.67% | -87.50% | -6.45% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more